West Pharmaceutical Services, Inc. company logo
West Pharmaceutical Services, Inc. logo

WST Cash From Operations

Annual CFO

$653.40M$123.10M-15.85%

Summary

Current Value
As of today, WST annual cash from operations is $653.40M, down -15.85% on
Historical Performance
WST annual cash from operations is up +11.88% over the past 3 years, and up +77.94% over the past 5 years
All-Time High Comparison
WST annual cash from operations is currently -15.85% below its historical high of $776.50M set on
3-Year Low Comparison
WST annual cash from operations is at its 3-year low
Sector Comparison
WST annual cash from operations is higher than 93.29% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

WST Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations$653.40M-15.8%+11.9%+77.9%+374.5%
Quarterly Cash From Operations$197.20M+9.5%+16.8%+66.3%+310.8%
TTM Cash From Operations$693.80M-1.2%+6.1%+61.3%+382.8%
Price$275.52-18.2%+14.4%-10.4%+1251.3%
Annual Cash From Investing-$378.70M-2.7%-49.6%-66.1%-210.7%
Annual Cash From Financing-$622.60M-35.5%-270.4%-1591.8%-2654.9%
Annual Free Cash Flow$276.40M-33.3%-16.4%+14.8%+824.4%
Annual CAPEX$377.00M+4.1%+48.8%+198.3%+249.7%
Annual Net Income$492.70M-17.0%-25.6%+103.8%+578.6%

Cash From Operations Highs

WST Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y$776.50M-15.8%
5Y$776.50M-15.8%
All$776.50M-15.8%

Cash From Operations Lows

WST Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y$653.40Mat low
5Y$472.50MN/A+38.3%
All$15.61M+4087.0%

Cash From Operations History

YearValueChange
$653.40M-15.9%
$776.50M+7.3%
$724.00M+24.0%
$584.00M+23.6%
$472.50M+28.7%
$367.20M+27.2%
YearValueChange
$288.60M+9.6%
$263.30M+20.0%
$219.40M+3.3%
$212.40M+16.1%
$182.90M-

FAQ

  • What is the current annual cash from operations of WST?

    As of today, WST annual cash from operations is $653.40M

  • What is 1-year change in WST annual cash from operations?

    WST annual cash from operations is down -15.85% year-over-year

  • What is 3-year change in WST annual cash from operations?

    WST annual cash from operations is up +11.88% over the past 3 years

  • How far is WST annual cash from operations from its all-time high?

    WST annual cash from operations is currently -15.85% below its historical high of $776.50M set on December 31, 2023

  • How does WST annual cash from operations rank versus sector peers?

    WST annual cash from operations is higher than 93.29% of companies in Healthcare sector

  • When is WST next annual earnings release?

    The next annual earnings release for WST is on

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In

Data Sources & References

  1. WST Official Website www.westpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/105770/000010577025000093/0000105770-25-000093-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577025000013/0000105770-25-000013-index.htm
  4. WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
  5. WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst